Everolimus in heart transplantation: does it finally have a home? This editorial approves the use of everolimus to wean calcineurin inhibitors (by 7â€“11 weeks postoperative) as safe and effective with improved first-year renal function and reduced intimal thickness by intravascular ultrasound. See article by Andreassen et al on page 1828. 